After Teaming Up With Aurobindo And Claris, Pfizer Now Talks To Cipla On Supply Deal

MUMBAI - After signing long-term manufacturing and supply arrangements with India's Claris and Aurobindo Pharma, the world's largest drug maker, Pfizer, may select Cipla as a third partner to grow the number of products being sold through its Established Products Business Unit